Do we overtreat or undertreat the axillary region in lymph node-positive breast cancer patients?

dc.contributor.authorCelik, O. Karakoyun
dc.contributor.authorHoca, S.
dc.contributor.authorBolukbasi, Y.
dc.contributor.authorOlacak, N.
dc.contributor.authorHaydaroglu, A.
dc.date.accessioned2019-10-27T19:57:04Z
dc.date.available2019-10-27T19:57:04Z
dc.date.issued2008
dc.departmentEge Üniversitesien_US
dc.description50th Annual Meeting of the American-Society-for-Therapeutic-Radiology-and-Oncology -- SEP 21-25, 2008 -- Boston, MAen_US
dc.description.sponsorshipAmer Soc Therapeut Radiol & Oncolen_US
dc.identifier.endpageS172en_US
dc.identifier.issn0360-3016
dc.identifier.issue1en_US
dc.identifier.startpageS171en_US
dc.identifier.urihttps://hdl.handle.net/11454/40901
dc.identifier.volume72en_US
dc.identifier.wosWOS:000258805300384en_US
dc.identifier.wosqualityQ1en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.language.isoenen_US
dc.publisherElsevier Science Incen_US
dc.relation.ispartofInternational Journal of Radiation Oncology Biology Physicsen_US
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.titleDo we overtreat or undertreat the axillary region in lymph node-positive breast cancer patients?en_US
dc.typeConference Objecten_US

Dosyalar